Clinical assessment of assays for diagnosis of herpes simplex infection

Expert Review of Molecular Diagnostics

Volumn 6, Issue 5, 2006, Pages 767-775

  Ryan, Claire ^a   Kinghorn, George ^b,c  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Genital herpes; Herpes simplex viruses; HSV; Nucleic acid amplification test; PCR; Polymerase chain reaction; Type specific serology

Indexed keywords

CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; NEWBORN INFECTION; NUCLEIC ACID AMPLIFICATION; REVIEW; SERODIAGNOSIS; VIRUS CULTURE; VIRUS TRANSMISSION;

DIAGNOSTIC TESTS, ROUTINE; DISEASE TRANSMISSION; DISEASE TRANSMISSION, INFECTIOUS; DNA, VIRAL; HERPES SIMPLEX; HUMANS; SIMPLEXVIRUS;

EID: 33749536067     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.5.767     Document Type: Review

References (91)

1. Slomka MJ, Emery L, Munday PE, Moulsdale M, Brown DW. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J. Med. Virol. 55, 177-183 (1998).
2. Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin. Med. 69, 381-383 (1993).
3. Tayal SC, Pattman RS. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-1992. Int. J. STD AIDS 6, 144 (1995).
4. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 181, 1454-1457 (2000).
5. Vyse AJ, Gay NJ, Slomka MJ et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex. Transm. Infect. 76, 183-187 (2000).
6. Cowan FM, Copas A, Johnson AM, Ashley R, Corey L, Mindel A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex. Transm. Infect. 78, 346-348 (2002).
7. Fleming DT, McQuillan GM, Johnson RE et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337, 1105-1111 (1997).
8. Whitley RJ. Neonatal herpes simplex virus infections. J. Med. Virol. Suppl. 1, 13-21 (1993).
9. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr. Perinat. Epidemiol. 10, 432-442 (1996).
10. Braig S, Chanzy B. Management of genital herpes during pregnancy: the French experience. Herpes 11, 45-47 (2004).
11. Smith J, Robinson N. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186(Suppl.), S3-S28 (2002).
12. Chen CY, Ballard RC, Beck-Sague CM et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex. Transm. Dis. 27, 21-29 (2000).
13. Kaul R, Kimani J, Nagelkerke NJ et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 291, 2555-2562 (2004).
14. Gray RH, Wawer MJ, Brookmeyer R et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual couples in Rakai, Uganda. Lancet 357, 1149-1153 (2001).
15. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex type-2 sero-positive persons: a meta-analysis. J. Infect. Dis. 185, 45-52 (2002).
16. Solomon L, Cannon MJ, Reyes M, Graber JM, Wetherall NT, Reeves WC. Epidemiology of recurrent genital herpes simplex virus types 1 and 2. Sex.Transm. Infect. 79, 456-459 (2003).
17. Mindel A. Cutaneous herpes simplex infections. Scand. J. Infect. Dis. Suppl. 80, 47-52 (1991).
18. Gottlieb SL, Douglas JM, Schmid DS et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J. Infect. Dis. 186, 1381-1389 (2002).
19. Nahmias A. Neonatal HSV infection part 1: continuing challenges. Herpes 11, 33-37 (2004).
20. Brown ZA, Wald A, Ashley Morrow R, Selke S, Zeh J, Corey L. Effect of serologic status and caesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289, 203-209 (2003).
21. Kinghorn GR. Acute and recurrent genital herpes simplex virus infection. In: Herpes Simplex Viruses. Studahl M, Cinque P, Bergstrom T (Eds), Marcel Dekker, (2006) (In press).
22. Patel R, Barton SE, Brown D et al. European guidelines for the management of genital herpes. Int. J. STD. AIDS Suppl. 3, 34-39 (2001).
23. Corey L, Wald A, Patel R et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350, 11-20 (2004).
24. Patel R. Educational interventions and the prevention of herpes simplex virus transmissions. Herpes 11(Suppl. 3), A155-A160 (2004).
25. Wald A, Langenberg AG, Link K et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 285, 3100-3106 (2001).
26. Stellrecht KA. Nucleic acid amplification technology for the diagnosis of genital herpes infection. Expert Rev. Mol. Diagn. 4, 485-493 (2004).
27. Koutsky LA, Ashley RL, Holmes KK et al. The frequency of unrecognised type 2 herpes simplex infection among women. Implications for the control of genital herpes. Sex. Trans. Dis. 17, 90-94 (1990).
28. Geretti AM, Brown DW. National survey of diagnostic services for genital herpes. Sex. Trans. Infect. 81, 316-317 (2005).
29. Mindel A, Coker DM, Faherty A, Williams P. Recurrent genital herpes: clinical and virological features in men and women. Genitourin. Med. 64, 103-106 (1988).
30. Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV). DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J. Infect. Dis. 188, 1345-1351 (2003).
31. Lafferty W, Krofft S, Remington M et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population. J. Clin. Microbiol. 25, 323-326 (1987).
32. Langenberg A, Zbanyszek R, Dragavon J, Ashley R, Corey L. Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J. Clin. Microbiol. 26, 1772-1774 (1988).
33. Moore DF. Comparison of human fibroblast cells and primary rabbit kidney cells for isolation of herpes simplex virus. J. Clin. Microbiol. 19, 548-549 (1984).
34. Callihan DR, Menegus MA. Rapid detection of herpes simplex virus in clinical specimens with human embryonic lung fibroblast and primary rabbit kidney cell cultures. J. Clin. Microbiol. 19, 563-565 (1984).
35. Gleaves C, Wilson D, Wold A, Smith T. Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16h postinoculation. J. Clin. Microbiol. 21, 29-32 (1985).
36. Stabell E, O'Rourke S, Storch G, Olivo P. Evaluation of a genetically engineered cell line and a histochemical β-galactosidase assay to detect herpes simplex virus in clinical specimens. J. Clin. Microbiol. 32, 2796-2798 (1993).
37. Turchek B, Huang Y. Evaluation of ELVISTM HSV ID/typing system for the detection and typing of herpes simplex virus from clinical specimens. J. Clin. Virol. 12, 65-69 (1999).
38. Crist GA, Langer JM, Woods GL, Procter M, Hillyard DR. Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens. Diagn. Microbiol. Infect. Dis. 49, 173-177 (2004).
39. Espy M, Wold A, Jespersen D, Jones M, Smith T. Comparison of shell vials and conventional tubes seeded with rhabdomyosarcoma and MRC-5 cells for the rapid detection of herpes simplex virus. J. Clin. Mirobiol. 29, 2701-2703 (1991).
40. Safrin S, Elbeik T, Mills J. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J. Infect. Dis. 169, 879-882 (1994).
41. Safrin S, Elbeik T, Phan L et al. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38, 1246-1250 (1994).
42. Scoular A, Gillespie G, Carman WF. Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex. Trans. Infect. 78, 21-25 (2002).
43. Ramaswamy M, McDonald C, Smith M et al. Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex. Trans. Infect. 80, 406-410 (2004).
44. Espy MJ, Uhl JR, Mitchell PS et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J. Clin. Microbiol. 38, 795-799 (2000).
45. Corey L, Huang ML, Selke S, Wald A. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J. Med. Virol. 76, 350-355 (2005).
46. Hobson A, Wald A, Wright N, Corey L. Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions. J. Clin. Microbiol. 35, 548-552 (1997).
47. Wiedbrauk DL, Cunningham W. Stability of herpes simplex virus DNA in cerebrospinal fluid specimens. Diagn. Mol. Pathol. 5, 249-252 (1996).
48. Jerome KR, Huang ML, Wald A, Selke S, Corey L. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J. Clin. Microbiol. 40, 2609-2611 (2002).
49. Barnard DL, Farnes K, Richards DF, Croft GF, Johnson FB. Suitability of new chlamydia transport medium for transport of herpes simplex virus. J. Clin. Microbiol. 24, 692-695 (1986).
50. Schloss L, van Loon AM, Cinque P et al. An international external quality assessment of nucleic acid amplification of herpes simplex virus. J. Clin. Virol. 28, 175-185 (2003).
51. Hirsch HH, Bossart W. Two-centre study comparing DNA preparation and PCR amplification protocols for herpes simplex virus detection in cerebrospinal fluids of patients with suspected herpes simplex encephalitis. J. Med. Virol. 57, 31-35 (1999).
52. Ryncarz A, Goddard J, Wald A, Huang M, Roizman B, Corey L. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J. Clin. Microbiol. 37, 1941-1947 (1999).
53. Hogrefe W, Xin S, Song J, Ashley R, Kong L. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, western blotting, and gG2 inhibition. J. Clin. Microbiol. 40, 2635-2640 (2002).
54. Morrow RA, Friedrich D. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2. Am. J. Clin. Pathol. 120, 839-844 (2003).
55. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex. Trans. Infect. 77, 232-237 (2001).
56. Ashley RL. Type-specific antibodies to HSV-1 and 2: review of methodology. Herpes 5, 33-38 (1998).
57. Lee FK, Colman RM, Pereira L et al. Detection of herpes simplex virus type-2 specific antibody with glycoprotein G. J. Clin. Microbiol. 22, 641-644 (1985).
58. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26, 662-667 (1988).
59. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DW. Monoclonal antibody blocking tests for the detection of HSV-1 and HSV-2 humoral responses: comparison with western blot assay. J. Virol. Methods. 55, 27-35 (1995).
60. Ashley RL, Linxian W, Pickering J, Ming-Chieh T, Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. Clin. Microbiol. 36, 294-295 (1998).
61. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV). type-1 specific and HSV type 2-specific IgG antibodies. J. Clin. Analysis 14, 14-16 (2000).
62. Koutsky LA, Stevens CE, Holmes KK et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N. Engl. J. Med. 326, 1533-1539 (1992).
63. Langenberg A, Corey L, Ashley RL, LeongW, Straus S. A prospective study of new infections with herpes simplex virus type 1 and type 2. N. Engl. J. Med. 341, 1432-1438 (1999).
64. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus on pregnant women in Stockholm in 1969, 1983 and 19989: implications for STD epidemiology. Int. J. STD. AIDS 5, 113-116 (1994).
65. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin. Microbiol. Rev. 12, 1-8 (1999).
66. Ashley-Morrow R, Nollkamper J, Robinson N, Bishop N, Smith J. Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1). and HSV-2 antibodies among young women in ten diverse geographical locations. Clin. Microbiol. Infect. 10, 530-536 (2004).
67. Layendecker O, Henson C, Gray R. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type specific antibodies in Ugandans. J. Clin. Microbiol. 42, 1794-1796 (2004).
68. Golden M, Ashley-Morrow R, Swenson P et al. Herpes simplex virus type 2 (HSV-2). western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex. Transm. Dis. 32, 771-777 (2005).
69. Bernstein DI, Lovett MA, Bryson YJ. Serologic analysis of first-episode non-primary genital herpes simplex virus infection. Am. J. Med. 77, 1055-1060 (1984).
70. Lee F, Pereira L, Griffin C, Reid E, Nahmias A. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J. Virol. Methods. 14, 111-118 (1986).
71. Gopal R, Gibbs T, Slomka MJ et al. A monoclonal blocking EIA for herpes simplex virus type 2 (HSV-2) antibody: validation for seroepidemiological studies in Africa. J. Virol. Methods (2001).
72. Scoular A, Kinghorn G on behalf of the MSSVD Special Interest Group on Genital Herpes and the British Co-operative Clinical Group. British co-operative clinical group national survey on diagnostic issues surrounding genital herpes. Sex. Transm. Infect. 75, 183-187 (1999).
73. Wald A, Zeh J, Selke S et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic HSV-2 seropositive persons. N. Engl. J. Med. 342, 844-850 (2000).
74. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N. Engl. J. Med. 316, 1444-1449 (1987).
75. Brown ZA. HSV-2 specific serology should be offered routinely to antenatal patients. Rev. Med. Virol. 10, 145-153 (2000).
76. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J. Clin. Microbiol. 37, 1632-1633 (1999).
77. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 9, 38-45 (2002).
78. Fairley I, Monteiro E. Patient attitudes to type specific serological tests in the diagnosis of genital herpes. Genitourin. Med. 73, 259-262 (1997).
79. Whittington W, Celum C, Cent A, Ashley RL. Use of a glycoprotein G-based typespecific assay to detect antibodies to herpes simplex virus 2 among persons attending genitourinary medicine clinics. Sex. Transm. Dis. 28, 99-104 (2001).
80. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 99, 1092-1097 (1997).
81. Brown ZA, Benedetti J, Ashley R et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 325, 965-966 (1991).
82. Brown ZA, Selke S, Zeh J et al. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337, 509-516 (1997).
83. Harger JH, Amortegui AJ, Meyer MP, Pazin GJ. Characteristics of recurrent genital herpes simplex infections in pregnant women. Obstet. Gynecol. 73, 367-372 (1989).
84. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery; a systematic review. Obstet. Gynecol. 102, 1396-1403 (2003).
85. Watson-Jones D, Weiss H, Changalucha C et al. A randomised HSV2 suppressive treatment trial for HIV prevention: design, enrolment and follow-up. 16th Biennial Meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR). Abstract TO-703 (2005).
86. Stanberry LR, Spruance SL, Cunningham AL et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347, 1652-1661 (2002).
87. Skjeldestad FE. For the future II steering committee. Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine (Gardasil™) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk. The 43rd Annual Meeting of the Infectious Disease Society of America (IDSA). Abstract LB-8A (2005).
88. Health Protection Agency www.hpa.org.uk/infections/topics_az/hiv_and_sti/ sti-herpes/epidemiology/epidemiology.htm
89. Centers for Disease Control, Atlanta, USA. Sexually transmitted diseases guidelines, 2002. (GenitalHerpes). www.cdc.gov/mmwr/preview/mmwrhtml/rr5106a1. htm
90. International herpes Management Forum Guidelines. Diagnosis of genital HSV infection. www.ihmf.org/guidelines/summary7.asp HSV
91. Barton S, Brown D, Cowan F et al. On behalf of the BASHH Clinical Effectiveness Group. 2001 national guidelines for the management of genital herpes. www. bashh.org/guidelines/2002/hsv_0601.pdf